Robert Caiazzo
Overview
Explore the profile of Robert Caiazzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
2822
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Ponthaud C, Nassar A, Dokmak S, Bertrand T, De Martino J, Pastier C, et al.
Ann Surg
. 2025 Feb;
PMID: 40018739
Objectives: To identify risk factors for conversion, develop a predictive Conversion Risk Score (CRS), and assess the association between conversion and severe postoperative complications. Background: Conversion occurs in 15-30% of...
2.
Ladsous M, Deguelte S, Hindie E, Caiazzo R, Delemer B
Ann Endocrinol (Paris)
. 2025 Jan;
86(1):101704.
PMID: 39818302
Persistent primary hyperparathyroidism is defined as the persistence or recurrence of hypercalcemia within 6 months of parathyroid surgery. Recurrent primary hyperparathyroidism is defined as the recurrence of primary hyperparathyroidism more...
3.
Baratte C, Sebbag H, Arnalsteen L, Auguste T, Blanchet M, Benchetrit S, et al.
J Visc Surg
. 2025 Jan;
162(1):71-78.
PMID: 39794164
IS ESG EFFECTIVE IN THE TREATMENT OF OBESITY AND ASSOCIATEDCOMORBIDITIES?: Endoscopic Sleeve Gastroplasty (ESG) is more effective than lifestyle modifications alone for weight loss and improving obesity-related comorbidities. While it...
4.
Deslande M, Puig-Castellvi F, Castro-Dionicio I, Pacheco-Tapia R, Raverdy V, Caiazzo R, et al.
Mol Metab
. 2025 Jan;
92:102090.
PMID: 39746606
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterised by lipid accumulation in the liver and is often associated with obesity and type 2 diabetes. The gut microbiome recently emerged...
5.
Lassailly G, Caiazzo R, Goemans A, Chetboun M, Gnemmi V, Labreuche J, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39709138
Background & Aims: The aim of this study was to investigate the consequences of the histological progression of metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis on long-term survival after bariatric surgery....
6.
Raverdy V, Tavaglione F, Chatelain E, Lassailly G, De Vincentis A, Vespasiani-Gentilucci U, et al.
Nat Med
. 2024 Dec;
30(12):3624-3633.
PMID: 39653777
Metabolic dysfunction-associated steatotic liver disease (MASLD) exhibits considerable variability in clinical outcomes. Identifying specific phenotypic profiles within MASLD is essential for developing targeted therapeutic strategies. Here we investigated the heterogeneity...
7.
Lhomme L, Sermikli B, Haas J, Fleury S, Quemener S, Guinot V, et al.
Nat Commun
. 2024 Aug;
15(1):7173.
PMID: 39169003
Plasma growth differentiation factor-15 (GDF-15) levels increase with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) but the underlying mechanism remains poorly defined. Using male mouse models of obesity and...
8.
Remond A, Marciniak C, Lenne X, Chouraki V, Gobert M, Baud G, et al.
Ann Surg
. 2024 Aug;
280(5):825-834.
PMID: 39109429
Objective: To provide a nationwide description of postoperative outcomes and analysis of prognostic factors following adrenalectomy for metastases. Background: Adrenal glands are a common site of metastases in many malignancies....
9.
Muller O, Bauvin P, Bacoeur O, Michailos T, Bertoni M, Demory C, et al.
Ann Surg
. 2024 Aug;
280(5):835-841.
PMID: 39109425
Objective: We used machine learning to develop and validate a multivariable algorithm allowing the accurate and early prediction of postoperative hypocalcemia risk. Background: Postoperative hypocalcemia is frequent after total thyroidectomy....
10.
Peschard S, Raverdy V, Bauvin P, Goutchtat R, Touche V, Derudas B, et al.
Diabetes
. 2024 Mar;
73(6):983-992.
PMID: 38498375
Article Highlights: